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Background: The present study focuses on the program “Medical Insurance for the Poor (MIP)” in Georgia. Under
this program, the government purchased coverage from private insurance companies for vulnerable households
identified through a means testing system, targeting up to 23% of the total population. The benefit package
included outpatient and inpatient services with no co-payments, but had only limited outpatient drug benefits. This
paper presents the results of the study on the impact of MIP on access to health services and financial protection
of the MIP-targeted and general population.
Methods: With a holistic case study design, the study employed a range of quantitative and qualitative methods.
The methods included document review and secondary analysis of the data obtained through the nationwide
household health expenditure and utilisation surveys 2007–2010 using the difference-in-differences method.
Results: The study findings showed that MIP had a positive impact in terms of reduced expenditure for inpatient
services and total household health care costs, and there was a higher probability of receiving free outpatient
benefits among the MIP-insured. However, MIP insurance had almost no effect on health services utilisation and the
households’ expenditure on outpatient drugs, including for those with MIP insurance, due to limited drug benefits
in the package and a low claims ratio. In summary, the extended MIP coverage and increased financial access
provided by the program, most likely due to the exclusion of outpatient drug coverage from the benefit package
and possibly due to improper utilisation management by private insurance companies, were not able to reverse
adverse effects of economic slow-down and escalating health expenditure. MIP has only cushioned the negative
impact for the poorest by decreasing the poor/rich gradient in the rates of catastrophic health expenditure.
Conclusions: The recent governmental decision on major expansion of MIP coverage and inclusion of additional
drug benefit will most likely significantly enhance the overall MIP impact and its potential as a viable policy
instrument for achieving universal coverage. The Georgian experience presented in this paper may be useful for other
low- and middle-income countries that are contemplating ways to ensure universal coverage for their populations.
Keywords: Catastrophic expenditure, Financial protection, Health insurance for the poor, Service utilisation, Targeting
the poor, Universal coverageBackground
Georgia has chosen its own path in reforming the health
financing system by allocating general government reve-
nues to purchase relatively comprehensive coverage for
the poor identified through the means testing system.
The focus on priority groups and specifically on the poor
segments of the population is a common feature of health
financing reforms in other low- and middle-income coun-
tries (LMICs) [1-7]. Nonetheless, the Georgian experience* Correspondence: k.zoidze@curatio.com
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risk prepayment schemes and for most of these countries
private for-profit schemes are generally limited to the
wealthy minority [10]. Columbia and India are the only
other LMICs described in the literature that have estab-
lished a similar Public Private Partnership (PPP) for the
insurance of the poor [11,12].
In general, due to reduced bureaucratic process and
often better business practices, private health insurance
may be more efficient than public or quasi-public social
insurance schemes, although the efficiency gains may be
outweighed by higher administrative and acquisition costs
[13,14]. Most of the countries relying on voluntary health
insurance are commonly unable to extend coverage to the
majority of the population, or tend to leave large segments
of the population uncovered (e.g., South Africa, Jordan,
Lebanon, Zimbabwe, India) [10]. Fragmentation of the
national pools is another problem in countries where
mandatory coverage is provided through competing private
health insurance companies. These countries (Switzerland,
Netherlands and Czech Republic) are compelled to use
cross-subsidization between multiple pools to improve
equity and viability of the health financing system [15].
There is a consensus that public financing of health
care services for the population and particularly for the
poor tends to be more equitable and can provide better
financial protection [15,16]. However, global evidence is
inconclusive on the advantages or disadvantages of using
private for-profit insurance companies as financial inter-
mediaries in the provision of health insurance for the
population and its poorest segments through public funds
[13,17]. Moreover, there is a near absence of comprehen-
sive reviews of such experiences in LMICs [18]. These
factors and emerging challenges in the design and im-
plementation of Georgia’s health financing reform tar-
geting the poor [19] inspired a systematic study of the
Georgian experience in implementing the large-scale pre-
payment schemes through a public-private partnership.
By 2006, the government developed a proxy-means-
tested system for the detection of poor households. The
test includes over 100 variables to estimate a household’s
welfare standing. All Georgian households are entitled to
apply to be included in the poverty database managed by
the Social Services Agency (SSA). The households found
ineligible for the social assistance can reapply after one
year for a repeat eligibility assessment. SSA also con-
ducts regular reviews (at least once in every five years)
of the eligibility status of each household receiving the
social assistance. The system allows identification of the
poor with a sufficient degree of certainty [20,21]. This
targeting system was used for the delivery of medical in-
surance for the poor (MIP) benefits to the poor when
the MIP program was launched in 2007–2008. Beneficiar-
ies of MIP are chosen based on welfare scores derivedfrom a proxy means test. Households registered with
the SSA database with scores below 70,001 are eligible
for MIP. The MIP benefit package covers the following:
i) urgent outpatient and inpatient treatment, including
necessary diagnostic-laboratory tests to determine the
need for hospitalization; ii) planned inpatient services,
with an annual insurance limit of 15,000 GEL (1 GEL ~
0.6 US$), excluding expenses for cosmetic treatment,
aesthetic surgery, resort treatment, sexual disorders,
infertility, treatment abroad, sexually transmitted infec-
tions, HIV, and hepatitis C; iii) chemotherapy and radi-
ation therapy within 12,000 GEL annual insurance limit;
iv) outpatient visits and limited diagnostic and laboratory
tests prescribed by the family physician or general prac-
titioner; v) compensation for delivery costs (up to 400
GEL); vi) outpatient prescription drugs from a prede-
fined essential drugs list and with an annual limit of 50
GEL and with 50% co-payment.
Institutional and purchasing arrangements
Initially implemented through a public single payer in
September 2007, the government contracted out the
delivery of MIP benefits to Private Insurance Companies
(PICs). This move was most likely triggered by the Post
Rose Revolution emphasis by the Georgian leadership on
libertarian ideals and “small government” as a main tool
in fighting corruption [22]. All 14 PICs operating in
Georgia by the year 2007 had the right to participate.
The insurance companies contracted health services
from a network of predominantly private providers, or
provided these through their own clinics and hospitals.
Important changes were introduced in mid-2010. The
country was divided into 26 medical regions and three-
year contracts for each region were awarded to PICs
identified through the competitive tendering procedure.
Because of the tendering procedure, the annual insurance
premiums were brought down from 180 GEL in 2009 to
116–132 GEL (depending on the region). Since then, MIP
voucher holders are obliged to enter into insurance con-
tracts with PICs according to their place of residence.
However, beneficiaries have the right to change the insur-
ance carrier once a year, in case they are not satisfied with
the services provided. As an important addition, the PICs
that won tenders for MIP implementation were mandated
to construct/upgrade hospitals and medical centres in re-
spective medical regions to ensure access to quality health
services for the MIP beneficiaries insured by them.
While the concrete policy objectives for MIP were
never formulated explicitly in any legal or policy docu-
ment at the initial stage, two main objectives were
implied: i) “creation of a targeting system for public
financing of health services for the socially vulnerable”
and ii) “redirection of the public funds to support the
development of private insurance” [23]. Three explicit
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three years of implementation in 2011: i) to increase
financial access to health services for the targeted
groups of the population; ii) to mitigate the financial
burden induced by the health expenditure for the targeted
groups of the population; iii) to reduce the out-of-pocket
(OOP) expenditure in the health sector. Respectively,
three targets and indicators for the year 2012 were
determined: i) number of insured under MIP to reach
1,700,000; ii) reduction of the share of OOPs in total
health expenditure by 10%; iii) increased utilisation of
outpatient and inpatient services by 2–3% for the
population insured under MIP in 2010 [24].
One of the key objectives of this case study was to
assess the impact of these new health financing reform
initiatives of the Georgian government. In line with the
implicit and explicit MIP objectives described above, the
MIP impact was assessed in terms of equity of access to
essential health care services and financial protection
against the health care costs – which, together, are two
key dimensions of the universal coverage plans.Table 1 Selected economic, social and health indicators for G
1990
Economic Indicators
GDP per capita (PPP$) 4,433
GDP growth (annual%)
Public expenditure (% of GDP)
Population in 1,000 5,438
Social and Poverty
Subsistence minimum (average for household)
Poverty
Share of population with less than 60% of the median consumption
Share of population with less than 40% of the median consumption
GINI coefficient
Beneficiaries of poverty assistance (% of total population)
Health Status and Health System
Life expectancy at birth 73
Infant mortality (per 1,000 live births) 20.7
Hospitalizations per 100 population 13.31
Outpatient visits per capita 8
Health Financing
Total health expenditure (THE) (% of GDP)
Public expenditure on health (% of THE)
Private expenditure on health (% of THE)
External expenditure on health (% of THE)
THE (year 2005 PPP$) per capita
Out-of-pocket expenditure (% of private health expenditure)
Prepaid health expenditure (% of THE)
Public expenditure on health (% of total public expenditure)
Source: Geostat, National Bank of Georgia.This paper reflects key results and conclusions of the
case study, drawing on two years of in-country research
(from October 2010 through November 2012). The paper
first provides a brief description of the analytical frame-
work and methods used in the study. It then reviews the
study results on MIP impact and discusses in more detail
the factors that may explain the patterns of the observed
impact. MIP impact in this paper is assessed across two
dimensions: i) breadth, scope and depth of the achieved
coverage for the general population [25] and ii) access to
health services and financial protection for the MIP-
targeted and general population. Selected economic, so-
cial, demographic and health indicators for the country
are presented in Table 1.
Methods
The overall approach used for the presented research
was an exploratory and partially explanatory, holistic
single case study design.
A variety of qualitative and quantitative research methods,
including in-depth interviews with key informants, focuseorgia for the years 1990, 1993, 2000 and 2003–2010
1993 2000 2003 2004 2005 2006 2007 2008 2009 2010
1,437 2,218 2,951 3,220 3,611 4,044 4,687 4,905 4,776 5,073
1.8 11.1 5.9 9.6 9.4 12.4 2.0 −3.8 6.3
11.6 10.7 14.6 17.3 20.3 22.9 29.1 30.9 30.7
5,137 4,435 4,342 4,315 4,321 4,401 4,394 4,382 4,385 4436.4
141.5 160.7 178.7 198.9 214.6 216.0 225.3
24.6 24.1 23.3 21.3 22.1 21.0
10.9 10.1 9.4 9.2 9.5 8.8
38.85 40.37 40.78 36.3
6.4 8.4 9.9 9.7
72 71.3 72.1 71.6 74.0 74.3 75.1 74.2 73.6 74.4
27.6 22.6 24.8 23.8 19.7 18.4 14.1 14.3 14.9 12.0
7.02 4.51 4.81 5.49 5.71 6.01 6.33 7 7.09 7.5
5.3 1.4 1.8 2 2.1 2.2 1.95 2.1 2
7.4 8.5 8.5 8.6 8.4 8.2 8.7 10.1 10.2
16.7 15 15.4 19.5 21.6 18.4 20.7 23 23.1
73 72.4 69.8 71.2 72.1
5.1 9.2 10.5 5.8 4.8
141.7 232.9 262.1 302.9 339.1 384.6 433.0 499.0 510
99.4 99.5 99.0 99.0 98.5 97.9 96.3 94.1 90.6
22.7 19.9 23.3 27.2 29.9
4.6 5.87 5.4 5.7 5.7 4.2 4.9 6.1 6.3
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analysis were used to achieve a holistic understanding
of the studied phenomenon. The current paper mainly
focuses on the key findings obtained through the quan-
titative methods. Results of the policy analysis and more
details on qualitative research findings will be presented
in subsequent papers.
MIP impact and testing/identification of factors shap-
ing the MIP impact were analysed using secondary data
analysis of population based surveys – nationally repre-
sentative Georgia Household Health Utilisation and
Expenditure Surveys (HUES) 2007 [26] and 2010 [27],
and the report on the Georgia MIP Impact Evaluation
Survey (MIPIES) 2008 [28]. HUES 2007 and MIPIES
2008 were conducted in the initial phase of MIP im-
plementation and provided the necessary baseline to
evaluate the observed MIP impact across the criteria
identified above. The impact was evaluated by comparing
these baseline findings with the findings of the HUES
2010 that have generated comparable data for MIP tar-
geted poor population, and the poor and general popula-
tion not covered by MIP benefits (Table 2). Additional
results of these surveys on several key outcomes, including
health-related behaviours, were also considered to explain
the impact of MIP on access to and utilisation of health
services. The utilisation and health expenditure patterns
and probability of receiving free benefits by MIP-targetedTable 2 Data sources, their short description and their use fo
Data sources Description
Georgia Household Health Utilisation
and Expenditure Surveys (HUES) in
2007 and 2010
Baseline (in May–June 2007) and follo
surveys (June 2010) using the exact s
tools with nationally representative sa
approximately 3,200 in each wave. Th
information for all members of the h
and past sickness episodes, including
information on sickness and use of se
household expenditure for all cases t
the 30-day period prior to interview a
cases that occurred during the 12-mo
the interview.
Georgia Integrated Health Survey
(IHS)
Nationally representative household su
quarter for living standards and pover
other statistical purposes on approx. 3
2007 and approx. 6,700 households in
MIP Impact Evaluation Survey in
Georgia – MIPIES (World Bank, 2008)
The survey sample of approx. 3,500
balance of MIP beneficiaries and no
drawn from the MIP applicants data
the country accounting for 74% of t
The survey conducted in Novembe
collected information on a range o
utilisation of and OOP expenditure
curative services.and not-targeted populations were assessed through the
analysis of combined HUES 2007 and 2010 databases
using the difference-in-difference (DiD) approach with
logistic regression method; this method is also known as
a pre-post design with a control group [29]. The change
(or difference) in the outcome variable at the baseline
and follow-up of MIP implementation in the treatment
(or MIP covered individuals) and control group (non-
MIP insured) were compared. Three sets of outcome
variables were tested in the regression model: i) utilisa-
tion of services; ii) level of OOP expenditure related to
service utilisation; and iii) odds of receiving free benefits
without any co-payment. This method has been sug-
gested over pre-post comparison without a control
group because if a trend effect occurs during the same
period as policy implementation, a simple pre-post com-
parison would have incorrectly attributed the trend effect
to a policy impact. In a DiD framework, any trend affect-
ing the treatment and control groups equally will be re-
moved and the resulting net difference will be the pure
policy effect. The model used can be expressed as follows:
Y ¼ β0 þ β1  Tþ β2 MIPþ β3  T MIPð Þ þ e
Where, Y is the outcome variable of interest; T is a
time dummy (2007–2010); MIP is a dummy for MIP in-
sured, capturing possible differences between MIP andr the analysis presented
Use for the analysis presented
w-up cross-sectional
ame methodology and








The combined survey database was used to:
i) assess the utilisation and health expenditure
patterns and probability of receiving free benefits
by MIP targeted and not targeted population;





HUES 2007/2010 sample households were
included in the IHS for the respective quarter.
This allowed linking sickness, utilisation and
health expenditure data, collected in the HUES,
with the household consumption level, which
provides a proxy for income and is the basis of
poverty measurement in Georgia. The household
consumption levels established by IHS and HUES
2007/2010 findings on household health
expenditure were used by us to estimate the
catastrophic health expenditure rates.
households with a
n-beneficiaries was





Survey findings on utilisation and expenditure
on MIP beneficiaries and non-beneficiaries were
compared to the HUES 2007–2010 findings.
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baseline average; β_1 represents the time trend in the
control group; β_2 represents the differences between
the MIP and non-MIP beneficiaries in 2007; and β_3
represents the difference in the changes by 2010 [30].
The catastrophic health expenditure rates were esti-
mated by the researchers using the HUES 2007 and
2010 databases utilizing the methodology presented in
Gotsadze et al. [31]. For comparison, alternative esti-
mates for the same indicators were also obtained from
Rukhadze and Goginashvili [32]. Their estimates are
based on annual data obtained through the quarterly
Georgia Integrated Household Survey (IHS) implemented
by the Georgian Statistical Committee (GeoStat). Finally,
two national peer reviewers using the research team
network were contacted and asked to review the study
findings.
The researchers use the incidence of catastrophic health
expenditure to characterize the financial protection of the
population, while the access to health services are mea-
sured using the indicators for health services utilisation
and is analysed using a framework encompassing geo-
graphical access to health facilities, availability of medical
personnel, and financial accessibility [33]. Catastrophic
health expenditure is defined and estimated using meth-
odology suggested by Xu et al. [34]. These specific ana-
lyses finally informed the overall analysis on the MIP
impact presented in this paper.Results
Breadth, depth and height of the achieved coverage for
the general population
An overall description of the breadth, scope and depth
of coverage – or who is covered, what services and to
what extent services costs are covered – is presented in
Table 3. There has been a striking increase in the
coverage of health insurance since 2006, from less than
200,000 individuals to about 1.4 million individuals, or
almost one third of the total population by the end of
2010. Out of this number, MIP accounted for over 1
million individuals, or about 23% of the total population
and roughly 72% of the insured population from any
source. The rest of the population is entitled to limited
publicly funded health benefits, including mainly non-
personal, population based services. This scale of expan-
sion in the MIP coverage was achieved through an
impressive 50% increase in the public expenditure on
health. Since MIP inception, the public expenditure
on health has grown from 40 US$ per capita in 2006 to 61
US$ in 2010 in constant 2009 US$ prices [35]. MIP
accounted for 43% of the total health budget in 2010, with
the remaining 57% going to other health programs for the
general population.Reaching the poor
MIP has fared relatively well in reaching the poor.
Table 4 shows that in the period from 2007 to 2010 the
coverage of the poorest income quintile increased from
14.3% to 39.2%. This means that the poorest in Georgia
with the existing targeting system have received twice
the share of MIP insurance benefits they would have
received in a random allocation, performing on a par
with the most effective targeting programs in LMIC
[21], despite the fact that MIP coverage was also ex-
tended to a considerable share (13.1%) of better-off
households [27].Access to health services and financial protection of MIP
targeted and general population
Utilisation
The analysis of combined HUES 2007 and 2010 data-
bases show that the overall level of utilisation of health
care, considered as contact with any type of health pro-
vider, appears to have declined slightly between 2007 and
2010, with 1.9 contacts per person per annum in 2010
compared with 2.0 in 2007 (Table 5). However, this dif-
ference is not statistically significant. At the same time,
a decline in utilisation has occurred in urban areas,
while there was an increase in utilisation in rural areas,
from an initially lower level. Both of these changes are
statistically significant. The utilisation trends differ be-
tween the individuals with acute vs. chronic illnesses.
Individuals with acute sicknesses in the preceding 30 days
are more likely to report using health services and report
a substantial increase in utilisation from 2007, with 66%
consulting a health care provider in 2010 compared with
57% in 2007. However, the individuals with chronic ill-
nesses utilised less services resulting in zero net effect for
an overall use of services (Table 5). While there was no
overall increase in the utilisation of health services for the
general population, our analysis shows that the MIP bene-
ficiaries were 2% more likely to seek any health services
compared to non-beneficiaries. This difference, though
very small, is statistically significant (Table 6).
In the same period, there has been no improvement in
the utilisation of primary-level services. Approximately
51% of all first consultations in 2010 took place at primary
level, slightly lower than in 2007 (52.7%). Moreover, the
share of MIP beneficiaries utilizing the primary health
facilities for their first consultation decreased from 17.3%
in 2007 to 13.1% in 2010, with shares of MIP beneficiaries
utilising hospitals for the same purpose increasing at
almost the same rate from 21.3% in 2007 to 25.8% in
2010 (P <0.1) (Table 7). This suggests that MIP, contrary
to the stated governmental health policy objective, may
have encouraged the preferential use of hospitals’ out-
patient services over primary health care services.
Table 3 Breadth, scope and depth of coverage of state funded health programs and health insurance (2010)
State vertical programs covering
personal health services and
State funded or subsidized
Insurance programs
Population coverage Service coverage Cost coverage
(covered by the state program)
Urgent care (population over 60) 830,000 – approx. 19% of the total
population
Defined inpatient urgent conditions First 6 days of ICU care, 75% of actual
cost for predefined conditions
Urgent and hospital care for
children under 3 years of age
220,000 – 5% Defined urgent and inpatient
conditions
Full cost in case of critical conditions
and population residing in high
mountainous areas; 80% of actual cost
for predefined inpatient conditions
General outpatient care Little over 1 million – approx. 22%
(children under-6, elderly over 60,
oncologic and diabetes patients)
Visits to Primary Health Care (PHC)
physician/nurse, 4 home visits,
immunization, limited list of express
lab tests, management of the
chronic diseases
Fully covered/no co-payment
Rural outpatient care “rural
physician”
Little over 2 million – approx. 47% Visits to PHC physician/nurse, 4
home visits, immunization, limited
list of express lab tests, management
of the chronic diseases
Fully covered/no co-payment
Maternal child health Women of reproductive age and
children
Four prenatal visits for all. Defined
list of tests, extended care for high
risk pregnancies and complicated
delivery
Upper limit from 833 to 3,000 GEL for
complicated pregnancy and delivery
Emergency care (ambulance) Entire population Ambulance service, medical
transportation
Fully covered/no co-payment
Referral program Entire population Medical needs during emergency
situations, MIP eligible beneficiaries
not yet insured; individual cases
Fully covered/no co-payment
Cardiac surgery Entire population Defined conditions; waiting list for
planned interventions
Fully covered for children less than
18 years of age; from 50 to 75% of




Entire population Defined conditions; outpatient and
inpatient care
Fully covered for children less than
18 years of age; 70% of the predefined
price of defined interventions with
upper limits (e.g., chemotherapy)
Dialysis and renal transplantation Entire population Defined conditions Fully covered/no co-payment
TB control Entire population DOTS, outpatient and inpatient care Fully covered/no co-payment
Mental health Entire population Defined outpatient and inpatient
care
Fully covered/no co-payment
Other programs (war veterans,
draftees, etc.)
Small groups Defined list of outpatient and
inpatient care
Fully covered/no co-payment
MIP insurance About 885,000 poor below eligibility
threshold 70,000, about 55,000
between 70,000 and 100,000 scores;
about 65,000 other groups (teachers,
IDPs, orphans, etc.) – total about
1 million, or 22% of population
Comprehensive defined list of urgent
care, critical care and inpatient
services; defined list of outpatient
services, outpatient drug benefit from
essential drug list
Annual limits: planned inpatient
services – 15,000 GEL; chemotherapy
and radiation therapy – 12,000 GEL;
delivery – 400 GEL; outpatient drugs –
50 GEL, with 50% co-payment
Affordable insurance* 125,000 – 2% Urgent outpatient and inpatient care
and critical conditions; outpatient
services included in general
outpatient care program
Fully covered PHC. Annual limits:
Urgent outpatient care – 300 GEL;
critical care from 1,000 to 5,000 GEL,
with co-payment from 0–50%
*2010 data.
Source: compiled by authors.
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The HUES 2007/2010 found that most of the population
have access to a health facility within 30 minutes by their
usual means of transport and the proportion of house-
holds that do have access has increased significantly inrural areas, reaching 78% for the population as a whole by
2010. There has also been a significant increase in the
proportion of respondents (from 65 to 80%) who report
that doctors are present for at least 5 days a week at the
relevant health facility (Table 8).
Table 4 Coverage of the population by any health insurance
and by MIP insurance, by income quintiles, 2007 and 2010
Year Poorest 2nd 3rd 4th Richest
Percentage of population
reporting being covered
by any health insurance
(government, private or
employer)
2007 18.5 14.8 12.5 14.4 8.6
2010 39.9 31.1 26.6 23.7 26.2
Percentage of the population
in households covered by MIP
2007 14.3 13.2 8.3 9.3 4.2
2010 39.2 26.8 20.1 16.7 13.1
Source: Authors and MoLHSA 2011 [27].
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According to the HUES 2007/2010, while the OOP pay-
ments for all health care services has increased (Table 9),
selected financial access indicators for the general popu-
lation have slightly improved over time. Namely, the
proportion of individuals requiring hospitalisation but
could not afford it has declined slightly, but significantly,
from 3.9 to 2.6% (Table 10). Our analysis of the HUES
2007/2010 database shows less OOP expenditure for in-
patient services (−227 Gel per episode) and total monthly
health care payments (−27 Gel), and a higher probability
of receiving free inpatient (by 14%) and outpatient (by
18%) benefits for MIP-insured (Table 6). The magnitude
of a positive MIP impact on the poorest was more signifi-
cant where inpatient treatment costs decreased by 442
GEL and MIP has significantly improved the probability
of receiving free benefits of inpatient and outpatient ser-
vices by around 23% for this group. However, MIP insur-
ance had almost no effect on the beneficiary expenditure
for outpatient drugs and for chronic patients [30].Catastrophic health expenditure
The results on catastrophic health expenditure obtained
using the HUES 2007/2010 database show a dramatic in-
crease in the shares of the general population facing the
catastrophic health expenditure from 11.7% in 2007 to
24.8% in 2010 (Table 11).Table 5 Average numbers of consultations and utilisation of
Indicator
Average number of consultations / contacts per person per annum (all sourc
Average number of outpatient consultations (all types) per person per annum
Percentage of total population who reported being sick with any condition i
and consulted a healthcare providerb
Percentage of occurrences of acute illness in the past 30 days where a health
Notes: aSignificance of difference not tested; bStatistical significance of difference w
Source: Authors and MOLHSA 2011 [27].Discussion
Much of the focus of the GoG’s PHC reforms in the past
7 years have been directed at increased access to primary
health facilities and qualified medical personnel trained
in family medicine in rural areas, thus encouraging pa-
tients to use these services [22]. However, the low overall
utilisation rates of health services for the general popula-
tion (two contacts per capita per year) that remained vir-
tually unchanged in the period from 2007 through 2010,
and the decline in the share of outpatient visits at PHC
facilities, indicate serious failure in achieving this im-
portant health policy objective of improved access to pri-
mary health care services for the Georgian population.
The World Bank assessment of the first 6 months of
MIP implementation revealed that MIP beneficiaries were
nine times more likely to utilize urgent care than house-
holds that were not qualified, utilisation also increased
among the poorest of the poor [36]. This impressive
growth in acute care utilisation among MIP beneficiaries
reported by the 2006 study is not upheld by the subse-
quent MIPIES 2008 and our study findings on utilisation.
Our findings of moderate MIP effects on utilisation are
consistent with the effects found by other studies of simi-
lar programs targeted at the poor [37].
MIPIES 2008 found that OOP payments by MIP benefi-
ciaries were about 50% lower for outpatient services and
40% to 58% lower for inpatient services compared to what
non-beneficiaries have spent. MIP beneficiaries were 17%
to 26% more likely to receive free care, had lower risk of
high inpatient medical care costs and were much less likely
to forgo services due to financial reasons [37]. These results
on MIP beneficiaries having less OOPs and higher likeli-
hood of receiving free care are consistent with our study
findings obtained through the DiD regression model.
The MIP benefit package has been steadily expanding
since inception of the MIP. However, the benefit package
as of November 1, 2012 still fails to cover the bulk of
essential outpatient services and most importantly, a
drug benefit for the chronically ill, which is one of the
main cost drivers for health services and a source ofservices when sick – HUES 2007/2010
Year Total Urban Rural
es of care)b 2007 2.01 2.36 1.67
2010 1.91 1.85*** 1.97**
a 2007 1.74 2.03 1.46
2010 1.66 1.60 1.72
n last 6 months 2007 59.5 59.8 59.3
2010 60.3 59.6 60.9
care provider was consultedb 2007 56.5 55.6 57.9
2010 66.0*** 68.0*** 64.3*
ith baseline figure: ***P <0.01; **P <0.05; *P <0.1.
Table 6 Results of Difference-in-Difference analysis using two waves of 2007/2010 HUES data
Outcome variables Single difference Double difference
Coefficient t-statistic Coefficient t-statistic
Service utilisation
Utilising any services during last 30 days 0.02 2.72** 0.02 1.95*
Utilising medical (curative and preventive) services during last 30 days 0.03 3.99*** 0.02 1.71*
Referring to self-treatment −0.01 −1.25 0 0.47
Outpatient utilization (binary) 0.02 2.16** 0.02 1.18
Inpatient service utilization (binary) 0.02 2.80*** 0.01 1.34
Household expenditure
Average payment per outpatient visit −24.56 −4.63*** −10.51 −1.3
Monthly self-treatment cost −4.84 −2.77*** −5.3 −2.13**
Average payment per inpatient stay −402.94 −3.50*** −226.93 −1.98*
Monthly chronic disease management costs −4.84 −2.77*** −4.98 −1.96*
Total monthly health care payments −5.65 −4.31*** −27.01 −1.94*
Probability of receiving free benefits
Outpatient free benefit 0.28 9.04*** 0.18 3.89***
Inpatient free benefit 0.35 7.77*** 0.14 1.77*
*P <0.10, **P <0.05, ***P <0.01.
Source: Gotsadze et al. [31].
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of the MIP benefit package was mostly oriented towards
inpatient services with limited outpatient coverage. After
three years of full-scale implementation, the benefit pack-
age was gradually expanded covering some additional in-
strumental and diagnostic services and a very limited
outpatient drug benefit in 2010. Nevertheless, the pharma-
ceutical treatment for chronic diseases remains the main
trigger for increased health expenditure and a potential
source of catastrophic health expenditure even for MIPTable 7 Population reporting to be sick consulting health prov
Indicator
Percentage of total population who reported to be sick in the last 6 months
Percentage of total population who reported to be sick in the last 6 months
consulted healthcare provider
Percentage of all first consultations, for last consultation in the last 6 months
that are done at a PHC level
Percentage of occurrences of acute sickness in last 30 days, where a health c
provider was consulted
Place of first consultation at village ambulatory centre, for most recent consulta
in previous six months
Place of first consultation at hospital as an outpatient, for most recent consu
in previous six months
Person consulted is village or district doctor, for most recent consultation in pre
six months (all consultations)
Notes: Statistical significance of difference between 2010 and 2007 estimates **P <
Source: Authors and MoLHSA 2011 [27].beneficiaries, as pharmaceutical expenditure accounts for
up to 50% of THE and up to 60% of households health
expenditure [35].
Our results on catastrophic health expenditure obtained
using the HUES 2007/2010 database show that the
poorest quintile households were more likely to face
catastrophic expenditure than other consumption quin-
tile groups. The share of such households with cata-
strophic health expenditure in the poorest quintile has
increased from 17.7% in 2007 to 27% in 2010. Yet, theider and place of first consultation, HUES 2007/2010 data
Year Total Urban Rural MIP Non-MIP
2007 53.5 56.2 51.0 67.3 51.7
2010 55.2* 56.0 54.5** 60.6 53.6
who 2007 59.5 59.8 59.3 58.4 59.8
2010 60.3 59.6 60.9 62.2 59.6
, 2007 52.7 52.4 53.1 59.0 49.8
2010 50.9 50.2 51.5 55.2 47.0
are 2007 56.5 55.6 57.9 56.2 63.3
2010 66.0 68.0 64.3 63.7 72.1
tion 2007 9.7 0.3 19.7 17.3 8.0
2010 8.9 0.2 17.6 13.1 7.4
ltation 2007 28.8 27.3 30.3 21.3 29.9
2010 29.5 28.5 30.5 25.8* 30.8
vious 2007 17.9 15.1 20.9 26.1 16.3
2010 18.1 16.7 19.5 23.7 16.1
0.05; *P <0.1.
Table 8 Physical access and availability of services – HUES 2007/2010
Indicator Year Total Urban Rural
Percentage of total population with access within 15 minutes by normal means of travel to a facility where they
would normally see a doctor
2007 42.4 55.6 31.4
2010 49.7*** 62.6** 37.6**
Percentage of total population with access within 30 minutes by normal means of travel to a facility where they
would normally see a doctor
2007 81.9 93.5 72.5
2010 85.5** 93.6 77.8*
Percent of health facilities (other than ambulatory) where a doctor is reported to be present for 5 or more days a week. 2007 98.1 99.3 95.9
2010 99.0* 99.4 98.0
Notes: Statistical significance of difference with baseline figure: ***P <0.01; **P <0.05; *P <0.1.
Source: Authors and MoLHSA 2011 [27].
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the same period declined by more than 20% (Table 11).
The analysis conducted by Rukhadze and Goginashvili
using the results of the Georgia Household Budget
Survey (HBS) show a similar trend. The actual values
for catastrophic expenditure for health derived from the
HUES are much higher than those reported by Rukhadze
and Goginashvili using the HBS data. This may be ex-
plained by a significantly higher level of health expend-
iture captured by HUES compared to HBS [31].
There is a seeming contradiction between improved
geographical access and financial access for both MIP
beneficiaries and the general population on the one side
and almost unchanged overall utilisation patterns, increased
OOP expenditure and worsened financial protection indi-
cators for the total population on the other that requires
explanation. There are at least three possible causes for the
observed effect.
Firstly, double negative impact of the war with Russia and
the global economic recession on the Georgian economy
and population welfare has significantly reduced households’
total consumption from 408.6 GEL in 2008 to 364.6
GEL in constant 2006 prices [32], while increase in total
and private health expenditure has outpaced the inflation
rate and GDP growth: total health expenditure (THE)
increased from 8.7% of GDP in 2008 to 10.2% of GDP in
2010, with private expenditure increasing from 69.8% to
72.1% of THE in the same period (Table 1). This ad-
versely affected the financial protection for the entireTable 9 Household health care expenditure (GEL, current pric
2007
Non-MIP M
Mean fee paid to a provider per outpatient visit 40.1 1
Mean cost per prescribed drug purchased 26.8 2
Mean expenditure per case of self-treatment 13.5 1
Annualized expenditure per chronic patient 276.2 2
Average cost per inpatient stay 636.8 4
Total annualized per capita expenditure 190.8 1
Notes: Statistical significance of difference with baseline figure: ***P <0.01; **P <0.0
Source: Authors and MoLHSA 2011 [27].population: OOP expenditure increased for all types of
services (Table 9) and catastrophic health expenditure
increased for all population groups, including the MIP
beneficiaries (Table 11). However, the increase in OOP
health expenditure, particularly for inpatient services,
disproportionally affected the non-MIP population,
while benefiting the MIP population (Table 9).
Secondly, the increase in private expenditure was most
notable for pharmaceuticals consumed on a daily basis
by 40% of the Georgian vulnerable households [38] and
mostly not covered by MIP. This expenditure amounted
to 50% of THE [35] and 60% of total household expend-
iture on health in 2010, which, in turn has increased by
21% in real terms in the period from 2007 through 2010
[27]. This dramatic increase in pharmaceutical expend-
iture may be related to irrational prescription practices
and the largely unregulated pharmaceutical market in
Georgia [22,39].
Thirdly, there is compelling evidence that despite the
extended breadth, depth and scope of coverage provided,
MIP was unable to shield the vast majority of the popula-
tion from catastrophic health expenditure. In the period
from 2008 through 2010, only 13.8% of MIP beneficiaries
used the insurance. In the same period, the claims ratio,
or the amount paid in claims against the total premium
amounted to the average of only 65% and in 45% of in-
surance cases reimbursed health expenditure did not
exceed 20 GEL (less than 5% of total household consump-
tion) [40]. Yet, this relatively low claims ratio, though notes) – HUES 2007/2010
2010
IP Total Non-MIP MIP Total
9.2 36.6 59.5** 21.8 54.2**
1.3 25.9 36.5*** 28.6** 35.4***
2.9 13.4 20.6*** 19.0** 20.4***
27.1 267.1 426.0*** 307.2*** 411.1***
14.4 599.2 730.7* 364.9 684.4
98.0 192.1 313.3** 278.4** 307.2**
5; *P <0.1.
Table 10 Financial access – HUES 2007/2010
Indicator Year Total MIP Non-MIP
Percentage of occurrences of acute sickness in the last 30 days, where no consultation was undertaken because
it was too expensive/not enough money (% of all reasons)
2007 16.1 15.3 16.2
2010 16.7 17.8 13.9
Percentage of consultations where medicine was prescribed but not purchased because it was too expensive
(base: all consultations in previous six months)
2007 11.8 19.4 10.3
2010 13.1 21.4 10.2
Percentage of consultations where a lab test was prescribed but not done because it was too expensive
(base: all consultations in previous six months)
2007 4.2 6.9 3.7
2010 4.2 5.0 4.0
Percentage of total population who reported needing hospitalisation in the last year but were not hospitalised
because it was too expensive/they did not have enough money
2007 3.9 - -
2010 2.6*** 2.3 2.7
Percentage of respondents who expect to pay for a consultation with a doctor at the nearest facility 2007 72.6 57.0 75.7
2010 73.5 51.5* 80.9**
Notes: ***P <0.01; **P <0.05; *P <0.1.
Source: Authors and MoLHSA 201 [27].
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intentional – in enrolment of the eligible beneficiaries
and aggressive utilisation management by some of the
participating PICs and poorly informed beneficiaries
[40]. Following this logic, curtailment of these adverse
practices and the increased beneficiary awareness may
have contributed to a significant increase in the claims
ratio in subsequent years, reaching 98% in 2012 [42].
Considering all the above, we suggest that the extended
MIP coverage and increased financial access provided by
the program, were most likely not able to reverse the ad-
verse effects of economic slow-down and escalating health
expenditure and have only cushioned the negative impact
for the poorest by decreasing the poor/rich gradient in the
rates of catastrophic health expenditure. Flaws in the MIP
benefit package and possible adverse practices employed
by the PICs may have played critical role in diminishing
the desired impact of MIP at the initial implementation
stage presented here.
Addressing problems in equity and financial protec-
tion against health care costs through re-attainment ofTable 11 Estimates of shares of households with
catastrophic health expenditure in 2007 and 2010 (%)
2007 2010
HUES HBS HUES HBS
Poorest 17.7 11.6 27.0 13.3
2nd quintile 12.0 6.3 27.9 9.8
3rd quintile 10.1 4.5 24.2 7.2
4th quintile 8.4 3.8 24.5 5.8
Richest 10.3 3.7 20.6 6.4
MIP 22.4
Non-MIP 35.2
Total 11.7 6.0 24.8 8.5
Source: Authors estimates for HUES 2007/2010; Rukhadze and Goginashvili for
HBS [32].universal coverage for essential health care services for
the entire population is one of the longstanding and ex-
plicitly stated national health policy goals in Georgia
[43]. However, the first practical steps towards achieve-
ment of this goal were made only in recent years, when
more funds became available to the health sector. Para-
doxically, this happened in the situation when the over-
arching goal of achievement of universal coverage for the
entire population was removed from the formal public
agenda in favour of the “selective” approach targeting
the priority groups [44]. The idea of providing universal
coverage to the entire population has re-emerged on the
policy agenda with the victory of the new political party
in Georgia in the fall of 2012. It is unclear whether the
existing PPP’s in providing health insurance coverage
will continue to exist and or which dimension of the
coverage (breadth, depth, or height) will be favoured as
a strategy towards achievement of this goal. The research
team believes that findings and results of the current study
may also help to inform policy makers to determine the
future path of the planned health financing reform.
The study limitations
In comparison to previous impact evaluation studies and
in consideration of policy implications of the findings, it
is important to keep the limitations of the study in mind.
First, given limitations of the data we have not consid-
ered the impact of the MIP on health outcomes. Second,
the inflation adjusted prices considered the conservative
approach by applying the overall Consumer Price Index
of Georgia and not the health-specific inflation rate (i.e.,
on average of 25% in year 2010). Thirdly, the consump-
tion groups assessed do not account for those receiving
government subsidies, hence there may be those belong-
ing in the “poor” quintile that may have consumed more
and hence be reported as higher quintile due to the
subsidy negatively distorting results characterizing the
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that since the research focused only on the first three
years of MIP implementation, it may have been too early
to assess its long-term effects. Further research is needed
to address these issues.
Conclusions
MIP has contributed to an improvement in all three
dimensions – population, service and cost coverage, and
managed to improve financial protection of the beneficiaries
that used health services against expenditure related to in-
patient care. This, in turn, had a positive impact on financial
access indicators for the poorest in the general population,
but had limited or no overall effect on utilisation of health
services and financial protection for the general population
as measured by the incidence of catastrophic health expend-
iture. The study results also suggest that the sustained low
utilisation of health services, particularly primary health care
services for the general population including MIP beneficiar-
ies is mainly determined by the limited financial accessibility
of outpatient pharmaceuticals. As a result, exclusion of an
outpatient drug benefit from MIP benefit package during
the first three years of implementation has detrimentally
affected the potential impact of MIP on financial pro-
tection of the population. There are also indications that
improper practices employed by the PICs – delayed en-
rolment and overly aggressive utilisation management –
may have also contributed to the low utilisation at the
initial stage of MIP implementation. Alternative approaches
to protecting households experiencing catastrophic health
expenditure might need to be explored, most important of
which may be the expansion of the MIP benefit package to
cover a reasonable outpatient drug benefit that will include
coverage of the leading causes of chronic illnesses such as
hypertension and other cardiovascular diseases, bronchial
asthma, gastroenterology disorders, etc. Policies for the
rationalization of unreasonably high pharmaceutical ex-
penditure should also be pursued.
The recent governmental decision on major expansion
of MIP coverage and inclusion of additional drug bene-
fits are expected to significantly enhance the overall MIP
impact and its potential as a viable policy instrument for
achieving universal coverage. However, it appears that
there is no clear consensus yet among policy makers in
which direction to proceed in for the further improve-
ment of the population’s financial protection, which pre-
sents a window of opportunity for the researchers and
advocacy groups to provide sound evidence and influence
the decision-making process.
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